765 related articles for article (PubMed ID: 20457157)
1. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R; Newbury R; Fox L; Bastian J; Aceves S
Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
[TBL] [Abstract][Full Text] [Related]
2. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Aceves SS; Bastian JF; Newbury RO; Dohil R
Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
[TBL] [Abstract][Full Text] [Related]
3. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
Sayej WN; Patel R; Baker RD; Tron E; Baker SS
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic variability in children with eosinophilic esophagitis.
Shah A; Kagalwalla AF; Gonsalves N; Melin-Aldana H; Li BU; Hirano I
Am J Gastroenterol; 2009 Mar; 104(3):716-21. PubMed ID: 19209168
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.
Konikoff MR; Noel RJ; Blanchard C; Kirby C; Jameson SC; Buckmeier BK; Akers R; Cohen MB; Collins MH; Assa'ad AH; Aceves SS; Putnam PE; Rothenberg ME
Gastroenterology; 2006 Nov; 131(5):1381-91. PubMed ID: 17101314
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.
Gonsalves N; Policarpio-Nicolas M; Zhang Q; Rao MS; Hirano I
Gastrointest Endosc; 2006 Sep; 64(3):313-9. PubMed ID: 16923475
[TBL] [Abstract][Full Text] [Related]
11. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
[TBL] [Abstract][Full Text] [Related]
12. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
Rubinstein E; Hait EE; Mitchell PD; Lee JJ
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.
Dranove JE; Horn DS; Davis MA; Kernek KM; Gupta SK
J Pediatr; 2009 Jan; 154(1):96-100. PubMed ID: 18783791
[TBL] [Abstract][Full Text] [Related]
14. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Felder S; Kummer M; Engel H; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Gastroenterology; 2010 Nov; 139(5):1526-37, 1537.e1. PubMed ID: 20682320
[TBL] [Abstract][Full Text] [Related]
15. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis.
Nielsen JA; Lager DJ; Lewin M; Rendon G; Roberts CA
Am J Gastroenterol; 2014 Apr; 109(4):515-20. PubMed ID: 24445569
[TBL] [Abstract][Full Text] [Related]
16. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
[TBL] [Abstract][Full Text] [Related]
18. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
[TBL] [Abstract][Full Text] [Related]
19. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
20. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.
Gonsalves N; Yang GY; Doerfler B; Ritz S; Ditto AM; Hirano I
Gastroenterology; 2012 Jun; 142(7):1451-9.e1; quiz e14-5. PubMed ID: 22391333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]